Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Acerta Pharma BV
BeOne Medicines
Boryung Pharmaceutical Co., Ltd
Janssen Pharmaceutical K.K.
Xencor, Inc.
BeiGene
BeiGene
X4 Pharmaceuticals
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Agenus Inc.
TG Therapeutics, Inc.
Karyopharm Therapeutics Inc
TG Therapeutics, Inc.
ADC Therapeutics S.A.
Pharmacyclics LLC.
Eli Lilly and Company
Pharmacyclics LLC.
Celgene
Gilead Sciences
Calithera Biosciences, Inc
AEterna Zentaris
Idera Pharmaceuticals, Inc.
Janssen Research & Development, LLC
GlaxoSmithKline
Amgen
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Pharmacyclics LLC.
Vertex Pharmaceuticals Incorporated
MedImmune LLC